1. Carvedilol Prevents Redox Inactivation of Cardiomyocyte β1-Adrenergic Receptors
- Author
-
Susan F. Steinberg and Misun Park
- Subjects
0301 basic medicine ,Cardioprotection ,Adrenergic receptor ,Chemistry ,Pharmacology ,medicine.disease_cause ,03 medical and health sciences ,030104 developmental biology ,Apoptosis ,medicine ,Cardiology and Cardiovascular Medicine ,Protein kinase A ,Receptor ,Protein kinase B ,Carvedilol ,Oxidative stress ,medicine.drug - Abstract
The mechanism that leads to a decrease in β1-adrenergic receptor (β1AR) expression in the failing heart remains uncertain. This study shows that cardiomyocyte β1AR expression and isoproterenol responsiveness decrease in response to oxidative stress. Studies of mechanisms show that the redox-dependent decrease in β1AR expression is uniquely prevented by carvedilol and not other βAR ligands. Carvedilol also promotes the accumulation of N-terminally truncated β1ARs that confer protection against doxorubicin-induced apoptosis in association with activation of protein kinase B. The redox-induced molecular controls for cardiomyocyte β1ARs and pharmacologic properties of carvedilol identified in this study have important clinical and therapeutic implications.
- Published
- 2018
- Full Text
- View/download PDF